iHuman Inc. (IH) Stock Overview
Explore iHuman Inc.’s financial performance, market position, analyst ratings, and future outlook.
iHuman Inc. (IH)
Key Financials
Key Financials
Market Cap
15.2M
P/E Ratio
1.37
EPS (TTM)
$0.24
ROE
0.08%
IH Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of iHuman Inc. (NYSE: IH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, iHuman Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IH on the NYSE shows an RSI of 53.02, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.77 for the NYSE listing.
Key metrics behind iHuman Inc.'s NYSE-traded stock include a P/E ratio of 1.37 and a market capitalization of 15.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IH on the NYSE.